Swissmedic News

Swissmedic Therapeutic Products Safety Communications DHPCs Batch Recalls

Swissmedic publishes consolidated listings of Direct Healthcare Professional Communications (DHPCs), Health Professional Communications (HPCs), batch recalls, and quality defect notices for human medicinal products, medical devices, and veterinary medicines. The listings include dates, affected product names, and the nature of the safety issue (e.g., potential visible particles after reconstitution, risk of severe hypercalcaemia, non-conforming sterility testing). No specific compliance actions or deadlines are imposed by this aggregation page itself.

How Patients Report Suspected Drug Side Effects in Switzerland

Swissmedic publishes guidance on adverse drug reaction reporting in Switzerland, informing patients, relatives, and healthcare professionals of their reporting pathways. Healthcare professionals must report serious or unknown adverse reactions within 15 days of diagnosis and non-serious reactions within 60 days, while pharmaceutical companies have their own reporting gateway via the ElViS portal. Patients and relatives can now report suspected side effects electronically through Swissmedic's dedicated web form without requiring medical expertise.

FAQ About mRNA COVID-19 Vaccine Safety

Swissmedic published a comprehensive FAQ addressing common questions about mRNA COVID-19 vaccine safety, efficacy against variants, common side effects, and authorization status. The FAQ confirms that vaccines continue to protect against severe COVID-19 disease and that temporary authorizations are under review for ordinary authorization. Healthcare professionals and consumers can access the latest information on potential adverse reactions and vaccination recommendations.